HLB Co., Ltd.
028300
Classement en actions
#4141
HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and... HLB Co., Ltd. operates in two distinct sectors: pharmaceutical production and naval construction. In South Korea, its maritime division produces and distributes a diverse range of lifeboats, catering to offshore platforms, drilling vessels, and passenger cruise liners. Its offerings include traditional, free-fall, and rescue boat designs. Beyond lifeboats, HLB's product portfolio extends to marine and yacht engines, hooks, and a variety of specialized vessels such as rigid inflatable (RIB), patrol, fishing, aluminum, and leisure boats, as well as fishery inspection ships and general safety equipment. The company further offers comprehensive support services, including inspection and repair of lifeboats and davits, service engineering training, and the provision of spare parts. On the pharmaceutical front, HLB is engaged in the development of Riboseranib, a targeted anti-cancer agent, and Apilia, a treatment specifically for ovarian cancer. Established in 1975, HLB Co., Ltd. is headquartered in Ulsan, South Korea.
Prix de l'action
$29.28
Capitalisation boursière
$3.89B
Changement (1 jour)
-1.40%
Changement (1 an)
-8.45%
Pays
KR
Échange HLB Co., Ltd. (028300)
Catégorie
Healthcare
Ratio P/B pour HLB Co., Ltd. (028300)
Ratio P/B au October 2026 TTM : 15.65
Selon les derniers rapports financiers et le cours de l'action de HLB Co., Ltd., le ratio cours/valeur comptable actuel (TTM) est 15.65. À la fin de 2023, le ratio P/B était de 12.31.
Historique du ratio P/B pour HLB Co., Ltd. de 2012 à 2026
Ratio P/B à la fin de chaque année
| Année | Ratio P/B | Changez |
|---|---|---|
| 2026 (TTM) | 15.65 | -5.53% |
| 2024 | 16.57 | 34.60% |
| 2023 | 12.31 | 162.53% |
| 2022 | 4.69 | -46.47% |
| 2021 | 8.76 | -19.54% |
| 2020 | 10.89 | -58.32% |
| 2019 | 26.12 | 50.87% |
| 2018 | 17.32 | -17.44% |
| 2017 | 20.97 | 262.79% |
| 2016 | 5.78 | -35.05% |
| 2015 | 8.90 | 6.84% |
| 2014 | 8.33 | 133.99% |
| 2013 | 3.56 | 31.96% |
| 2012 | 2.70 | 0.00% |
Ratio P/B pour des entreprises similaires ou concurrentes
| Entreprise | Ratio P/B | Différence de Ratio P/B | Pays |
|---|---|---|---|
| 6.251 | -60.07% |
US
|
|
| 13.2547 | -15.33% |
US
|
|
| 4.208 | -73.12% |
AU
|
|
| 6.1824 | -60.51% |
NL
|
|
| - | - |
CH
|
